The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
21 September 2021
Employment effect (start)
Foreseen end date
Description
Pharmaceutical company AstraZeneca is to create 100 new jobs in Dublin where it is to base a next-generation active pharmaceutical ingredient (API) manufacturing facility. The new plant will be located in Blanchardstown and will create 100 highly skilled jobs including scientists and engineers. The creation of further indirect jobs is also expected. This is AstraZeneca's first manufacturing plant in Ireland.
Eurofound (2021), AstraZeneca, Business expansion in Ireland, factsheet number 105271, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/105271.